Regulation of endothelial signaling networks. Nat Rev Immunol
At our clinic, patients who come in with chronic GI inflammation, SIBO residuals, or a history of NSAID-induced gastritis are the group most likely to report subjective improvement on BPC-157 within the first 30 days
Another large study showed that using GLP-1s may help prevent immune-related diseases in people with diabetes or obesity People with diabetes who took GLP-1 drugs had a lower chance of developing rheumatoid arthritis, gout, and osteoarthritis compared to people on other diabetes medications
This makes it particularly relevant in clinical contexts where someone has gut lining compromise alongside systemic inflammation, for example, long-term NSAID use for chronic pain
Examples include insulin, growth hormone, and oxytocin